Empowered Funds LLC Sells 29,999 Shares of LifeVantage Co. (NASDAQ:LFVN)

Empowered Funds LLC reduced its holdings in LifeVantage Co. (NASDAQ:LFVN) by 38.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,860 shares of the company’s stock after selling 29,999 shares during the quarter. Empowered Funds LLC owned approximately 0.39% of LifeVantage worth $857,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of LFVN. Copeland Capital Management LLC bought a new position in LifeVantage in the fourth quarter valued at about $65,000. Barclays PLC lifted its stake in shares of LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock valued at $507,000 after purchasing an additional 11,608 shares during the period. Ritholtz Wealth Management lifted its stake in shares of LifeVantage by 65.2% in the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock valued at $830,000 after purchasing an additional 18,682 shares during the period. HighTower Advisors LLC bought a new position in shares of LifeVantage in the 3rd quarter worth $638,000. Finally, Capital Management Corp VA acquired a new stake in shares of LifeVantage during the third quarter worth $5,073,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Craig Hallum initiated coverage on LifeVantage in a research note on Tuesday, January 14th. They issued a “buy” rating and a $35.00 target price on the stock. Lake Street Capital initiated coverage on shares of LifeVantage in a research report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price target on the stock.

LifeVantage Stock Up 0.7 %

LFVN opened at $18.56 on Tuesday. The stock has a market cap of $232.93 million, a P/E ratio of 33.14 and a beta of 0.84. LifeVantage Co. has a 12 month low of $5.22 and a 12 month high of $27.38. The company has a fifty day simple moving average of $19.78 and a 200 day simple moving average of $14.28.

LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.04 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.16 annualized dividend and a yield of 0.86%. LifeVantage’s dividend payout ratio (DPR) is currently 28.57%.

Insider Buying and Selling at LifeVantage

In related news, Director Raymond B. Greer sold 8,000 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $20.15, for a total transaction of $161,200.00. Following the sale, the director now directly owns 99,288 shares in the company, valued at $2,000,653.20. This trade represents a 7.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 20.65% of the company’s stock.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.